File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Quality of reporting in 41 randomized controlled clinical trials of Chinese medicine for cancer pain

TitleQuality of reporting in 41 randomized controlled clinical trials of Chinese medicine for cancer pain
Authors
KeywordsCancer Pain
Chinese Medicine
Quality Control
Issue Date2007
Publisher中國中西醫結合學會. The Journal's web site is located at http://xxhb.chinajournal.net.cn/
Citation
World Chinese Journal Of Digestology, 2007, v. 15 n. 35, p. 3764-3769 How to Cite?
AbstractAIM: To highlight the importance and necessity of quality assurance in clinical trial reporting by analyzing 41 papers on of Chinese medicine for cancer pain. METHODS: A search for clinical trial reports published from 1986 to 2006 on the effects, mechanisms, safety and application of Chinese herbal medicine in cancer pain management was conducted using the CBM, Chinese Medical Current Contents (CMCC) and Weipu (available since 1989) databases in Chinese, and PubMed and EMBASE in English. We evaluated the methodological quality of the articles, following the guidelines set forth in Levels of Evidence of Human Studies of Cancer in Complementary and Alternative Medicine by the National Cancer Institute (NCI) and Quality of Reporting of Randomized Controlled Trials of Herbal Medicine Interventions by Gagnier et al. RESULTS: Some research information was insufficiently reported, including methods of randomization, inclusion and exclusion criteria, outcome measurements, blinding and concealment, quality control and quality assurance of herbal preparations, and adverse events. CONCLUSION: Two crucial elements of high quality scientific reporting are the provision of sufficient research information and the transparency of research methodology. Insufficient reporting may be one of the major reasons. Chinese medicine is not widely and globally used to treat cancer pain.
Persistent Identifierhttp://hdl.handle.net/10722/188595
ISSN
2015 SCImago Journal Rankings: 0.104
References

 

DC FieldValueLanguage
dc.contributor.authorXu, Len_US
dc.contributor.authorWei, PKen_US
dc.contributor.authorSun, DZen_US
dc.contributor.authorLao, Len_US
dc.date.accessioned2013-09-03T04:10:29Z-
dc.date.available2013-09-03T04:10:29Z-
dc.date.issued2007en_US
dc.identifier.citationWorld Chinese Journal Of Digestology, 2007, v. 15 n. 35, p. 3764-3769en_US
dc.identifier.issn1009-3079en_US
dc.identifier.urihttp://hdl.handle.net/10722/188595-
dc.description.abstractAIM: To highlight the importance and necessity of quality assurance in clinical trial reporting by analyzing 41 papers on of Chinese medicine for cancer pain. METHODS: A search for clinical trial reports published from 1986 to 2006 on the effects, mechanisms, safety and application of Chinese herbal medicine in cancer pain management was conducted using the CBM, Chinese Medical Current Contents (CMCC) and Weipu (available since 1989) databases in Chinese, and PubMed and EMBASE in English. We evaluated the methodological quality of the articles, following the guidelines set forth in Levels of Evidence of Human Studies of Cancer in Complementary and Alternative Medicine by the National Cancer Institute (NCI) and Quality of Reporting of Randomized Controlled Trials of Herbal Medicine Interventions by Gagnier et al. RESULTS: Some research information was insufficiently reported, including methods of randomization, inclusion and exclusion criteria, outcome measurements, blinding and concealment, quality control and quality assurance of herbal preparations, and adverse events. CONCLUSION: Two crucial elements of high quality scientific reporting are the provision of sufficient research information and the transparency of research methodology. Insufficient reporting may be one of the major reasons. Chinese medicine is not widely and globally used to treat cancer pain.en_US
dc.languageengen_US
dc.publisher中國中西醫結合學會. The Journal's web site is located at http://xxhb.chinajournal.net.cn/en_US
dc.relation.ispartofWorld Chinese Journal of Digestologyen_US
dc.subjectCancer Painen_US
dc.subjectChinese Medicineen_US
dc.subjectQuality Controlen_US
dc.titleQuality of reporting in 41 randomized controlled clinical trials of Chinese medicine for cancer painen_US
dc.typeArticleen_US
dc.identifier.emailLao, L: lxlao1@hku.hken_US
dc.identifier.authorityLao, L=rp01784en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-41149113464en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-41149113464&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume15en_US
dc.identifier.issue35en_US
dc.identifier.spage3764en_US
dc.identifier.epage3769en_US
dc.publisher.placeChinaen_US
dc.identifier.scopusauthoridXu, L=36524242100en_US
dc.identifier.scopusauthoridWei, PK=8976704400en_US
dc.identifier.scopusauthoridSun, DZ=8987439300en_US
dc.identifier.scopusauthoridLao, L=7005681883en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats